Genetic variations in glutathione pathway genes predict cancer recurrence in patients treated with trans-urethral resection and bacillus calmette-guerin instillation for non-muscle invasive bladder cancer

• Hung-Lung Ke, MD,
• Jie Lin, PhD,
• Yuanqing Ye, PhD,
• Wen-Jeng Wu, MD, PhD,
• Hua Wei, PhD,
• Maosheng Huang, MD,
• David W. Chang, PhD,
• Colin P. Dinney, MD,
• Xifeng Wu, MD, PhD

Affiliations

Hung-Lung Ke, MD

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jie Lin, PhD

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Yuanqing Ye, PhD

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Wen-Jeng Wu, MD, PhD

Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Hua Wei, PhD

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Maosheng Huang, MD

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

David W. Chang, PhD

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Colin P. Dinney, MD

Departments of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Xifeng Wu, MD, PhD

Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA